Suppr超能文献

一个携带 ABCC8 E1506K 失活突变的家族中出现高胰岛素血症性低血糖症发展为妊娠期糖尿病和糖尿病。

Hyperinsulinemic hypoglycemia evolving to gestational diabetes and diabetes mellitus in a family carrying the inactivating ABCC8 E1506K mutation.

机构信息

Division of Endocrinology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.

出版信息

Pediatr Diabetes. 2010 Nov;11(7):505-8. doi: 10.1111/j.1399-5448.2009.00626.x.

Abstract

Congenital hyperinsulinism of infancy (CHI) is the most common cause of hypoglycemia in newborns and infants. Several molecular mechanisms are involved in the development of CHI, but the most common genetic defects are inactivating mutations of the ABCC8 or KCNJ11 genes. The classical treatment for CHI has been pancreatectomy that eventually leads to diabetes. More recently, conservative treatment has been attempted in some cases, with encouraging results. Whether or not the patients with heterozygous ABCC8 mutations submitted to conservative treatment may spontaneously develop type 2 diabetes in the long run, is a controversial issue. Here, we report a family carrying the dominant heterozygous germ line E1506K mutation in ABCC8 associated with persistent hypoglycemia in the newborn period and diabetes in adulthood. The mutation occurred as a de novo germ line mutation in the mother of the index patient. Her hypoglycemic symptoms as a child occurred after the fourth year of life and were very mild, but she developed glucose metabolism impairment in adulthood. On the other hand, in her daughter, the clinical manifestations of the disease occurred in the neonatal period and were more severe, leading to episodes of tonic-clonic seizures that were well controlled with octreotide or diazoxide. Our data corroborate the hypothesis that the dominant E1506K ABCC8 mutation, responsible for CHI, predisposes to the development of glucose intolerance and diabetes later in life.

摘要

婴儿先天性高胰岛素血症(CHI)是新生儿和婴儿低血糖症的最常见原因。几种分子机制参与了 CHI 的发展,但最常见的遗传缺陷是 ABCC8 或 KCNJ11 基因的失活突变。CHI 的经典治疗方法是胰腺切除术,最终会导致糖尿病。最近,一些病例尝试了保守治疗,取得了令人鼓舞的结果。杂合 ABCC8 突变的患者是否会在长期内自发发展为 2 型糖尿病,这是一个有争议的问题。在这里,我们报告了一个家族,该家族携带 ABCC8 的显性杂合胚系 E1506K 突变,与新生儿期持续性低血糖和成年期糖尿病有关。该突变是先证者母亲的新发胚系突变。她在 4 岁以后出现低血糖症状,且非常轻微,但在成年后出现葡萄糖代谢受损。另一方面,在她的女儿中,疾病的临床表现发生在新生儿期,且更为严重,导致强直阵挛性发作,用奥曲肽或二氮嗪可很好地控制。我们的数据证实了这样一种假设,即负责 CHI 的显性 E1506K ABCC8 突变易导致成年后葡萄糖耐量受损和糖尿病的发生。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验